
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Niox Group Plc | LSE:NIOX | London | Ordinary Share | GB00BJVD3B28 | ORD 0.08P |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
64.00 | 66.60 | 64.80 | 64.00 | 64.00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 33.3M | 16.1M | 0.0383 | 16.92 | 272.45M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
14:16:36 | O | 7,568 | 64.30 | GBX |
Date | Time | Source | Headline |
---|---|---|---|
01/12/2023 | 09:20 | UKREG | Niox Group PLC Total Voting Rights Update |
06/11/2023 | 11:44 | UKREG | Niox Group PLC Block Listing Applicationn |
02/11/2023 | 09:00 | UKREG | Niox Group PLC Total Voting Rights Update |
30/10/2023 | 10:52 | UKREG | Niox Group PLC Holding(s) in Company |
16/10/2023 | 08:58 | UKREG | Niox Group PLC Holding(s) in Company |
11/10/2023 | 09:09 | UKREG | Niox Group PLC Holding(s) in Company |
02/10/2023 | 06:00 | UKREG | Niox Group PLC Block Listing Interim Review |
27/9/2023 | 09:30 | UKREG | Niox Group PLC Holding(s) in Company |
26/9/2023 | 11:12 | ALNC | ![]() |
26/9/2023 | 06:00 | UKREG | Niox Group PLC Interim Results - Ended 30 June 2023 |
Niox (NIOX) Share Charts1 Year Niox Chart |
|
1 Month Niox Chart |
Intraday Niox Chart |
Date | Time | Title | Posts |
---|---|---|---|
30/11/2023 | 15:43 | NIOX GROUP - expertise in asthma diagnosis and management | 145 |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|---|---|---|---|
14:16:37 | 64.30 | 7,568 | 4,866.22 | O |
14:03:38 | 64.88 | 650 | 421.72 | O |
12:22:39 | 64.86 | 2,602 | 1,687.60 | O |
12:18:47 | 64.80 | 500 | 324.00 | AT |
11:26:56 | 64.00 | 23 | 14.72 | O |
Top Posts |
---|
Posted at 04/12/2023 08:20 by Niox Daily Update Niox Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker NIOX. The last closing price for Niox was 64.40p.Niox currently has 420,442,112 shares in issue. The market capitalisation of Niox is £272,446,489. Niox has a price to earnings ratio (PE ratio) of 16.92. This morning NIOX shares opened at 64p |
Posted at 27/9/2023 14:43 by earwacks Some inevitable profit taking. Pretty small really. Just bare in mind why would AZN hold 18% of the company? Yes the shares are quite expensive, thats because their cashflow is five times larger than last year. The ceo was absolutely right to point out risks and possible headwinds. They are exactly the same for the majority of companies in the world. They have earmarked a tiny amount to spend on the next stage of development for the company, around £2 million. Not exactly going to need a fundraise! Really cant think what AZN are waiting for. I suppose they can block any other predator, but by next year will cost them twice this price at least to buy the rest. |
Posted at 26/9/2023 09:38 by earwacks Yes Mufster they seem to have left off 2 top holders griffiths 27 percent and perhaps more interestingly Astra Zenica T 17 percent. No accounting for market madness right now. Even though this list is from last year Griffiths has been in it for sometime , maybe increasing his holding along the way but has always had a pretty big holding. Not sure when Astra got on board but obviously most think they will buy Niox at some stage. How much more do they want to pay? Seems bonkers |
Posted at 25/8/2023 09:09 by joseph moran DividendNIOX Niox Group AIM 2.5p 07-Jun-23NIOX 07-Jun-23 Dividend Announcement Ex-Dividend Date 17-Aug-23 Payment Date 15-Sep-23 |
Posted at 18/7/2023 07:09 by edwardt Boom! Seems like we are breathing life into share price as well as folks lungs |
Posted at 23/5/2023 19:43 by thedudie From 4 years ago ....Oxford, UK - 19 December 2019: Circassia ...announces that it has granted nil-cost options ("Options") today over 4,322,767 ordinary shares in the Company ("Ordinary Shares") to Ian Johnson, who was appointed as Executive Chairman of the Company on 5 December 2019, under the 2019 Performance Share Plan. The Options have been granted at nil-cost and will vest on the third anniversary of the date of grant and are exercisable until the tenth anniversary of the date of grant. Vesting is subject to either the share price reaching 62.4p Nearly there I would say .... He will be happy if it passes this hurdle! |
Posted at 18/5/2023 09:23 by earwacks Typical market reaction to news. We have seen a rapid rise in the share price in recent weeks. Stockopedia has Niox a PE of 34. Not sure if that is still the case Stockopedia are tirelessly slow to update. So a bit of profit taking is inevitable. Cant deny I havnt thought about it myself, but just seems a bit too risky to duck out at this stage.the volume of buys in recent weeks has been quite relentless and some hefty stakes too.Chris Mills Harwood trust said the 65p directors bonus would not happen under its own steam.Its only a few pence short now Chris! They get another tranche of bonus if it gets into the 70s. Its certainly not cheap, but on the other hand not that expensive for the sector. I dont who you could compare it to. Quite a stash of cash and more to come. More than enough for a decent divi or even a special.do they need that much to launch the home kit I wonder? At this stage I would prefer a predator to take away the decision about top slicing please! Gl all |
Posted at 18/5/2023 06:08 by bc4 NIOX GROUP PLCAGM Statement Oxford, UK - 18 May 2023: NIOX Group plc (AIM: NIOX), a medical device company focused on point of care asthma diagnosis and management, is holding its Annual General Meeting today at the Hayakawa Building, Edmund Halley Road, Oxford Science Park. Oxford OX4 4GB. Trading Update We are pleased to report that our business has continued to perform well, with total revenues in the first 4 months of the year up 21% compared with the same period in 2022. Our core Clinical business grew strongly with revenues up 28% compared with the same period in 2022. EMEA has continued to experience strong growth, and our Asia markets have also improved significantly. In the USA, our relatively new distributor partners are starting to make an increasing contribution to revenues in the region, which were up 16% year to date compared with 2022.Ian Johnson, NIOX's Executive Chairman, said: "I am pleased to report a continuing strong trading performance in the year to date, reflecting the successful execution of our strategy. The effect of the growth in revenues, robust margins and the lower level of overheads means that adjusted EBITDA for the full year is now likely to be significantly higher than management expectations at the start of the year. The Board believes that the cash generation and resources of the Group are now at a level where it is appropriate to commence the payment of a dividend. Further details of the timing and quantum of an initial dividend payment will be announced in due course. It does not get any better than that great update |
Posted at 16/5/2023 14:07 by bc4 Taken from NIOX websiteFeNO by NIOX® Introducing a simple and easy way to transform your asthma care.By accurately assessing airway inflammation, FeNO testing can help improve asthma patient outcomes in one simple test, right at the point-of-care. Trusted around the world With over 45 million FeNO tests completed worldwide, NIOX® is trusted by thousands of healthcare professionals every day. Find out how FeNO by NIOX® can help make your asthma care easier. |
Posted at 11/5/2023 08:03 by earwacks Last year as Circassia we got a 4 month update at the AGM on May 12th, ahead of expectations naturally. The share price was around 35p then dipped below 30p for a couple of weeks and then continued trading between 34 to 40p range. Since then we have seen the name change and capital reduction so my feeling is 50p is not overly expensive for the updates and expectations this year especially in light of China's market opening up and of course the possibility of the launch of a home kit at some stage. This year Niox AGM is scheduled for May 18th, which hopefully will include news on first 4 months trading this year GL all |
Posted at 08/3/2023 10:34 by earwacks Hold? Yesterday over 7.6 million sold and share price goes up. Today a 100 bot trade takes the share price down to 48p! Crazy. Trend is undeniable though:) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
ADVFN France ADVFN US ADVFN Korea |